Vitacid C

Sodium Ascorbate

Method of action: Antioxidant, Metabolic, Nutritive Agent, Regulating Redox Processes, Replenishing Vitamin C Deficiency, Vitamins

Treatment option: Beriberi, Anemia, Pregnancy, Addison Disease, Milk Ejection, Radiation Sickness, Nephropathy, Scurvy

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Vitacid C

Property	Description
Active ingredient	Sodium Ascorbate
Form	Tablet, Capsule, Oral/Injectable Solution
Pharmacological class	Water-Soluble Vitamin, Antioxidant
General purpose	Prevention and treatment of Ascorbic Acid Deficiency
Origin	Chemically Derived / Synthetic

The Identity and Classification of Vitacid C

Vitacid C is the commercial name for a medicinal and supplemental product that contains Sodium Ascorbate as its active ingredient. This compound is the monosodium salt of Ascorbic Acid (C6H7NaO6), universally known as Vitamin C. It is formally classified within the Pharmacological Class of Water-Soluble Vitamins and functions as a critical Antioxidant.

This classification defines its role primarily as a Nutrient Supplement necessary for human physiology, rather than a conventional drug targeting a specific disease pathway. The compound's primary purpose is the prevention and treatment of states of Ascorbic Acid Deficiency, such as Scurvy.

Composition: Sodium Ascorbate vs. Ascorbic Acid

The key compositional feature of Vitacid C is its reliance on Sodium Ascorbate, a formulation that is inherently buffered and significantly less acidic than pure Ascorbic Acid. This chemical distinction offers a crucial practical benefit: improved digestive tolerability. This makes it a preferred choice for individuals with gastrointestinal sensitivity or hyperacidity who require consistent intake of this essential vitamin.

Sodium Ascorbate is manufactured in several Pharmaceutical Preparations, including Chewable Tablets, Capsules, and Oral Solutions, primarily for Oral consumption. The availability of sterile Injectable Solutions also provides for specialized Intravenous administration when medically required.

General Purpose and Essential Action

The general purpose of Vitacid C is to correct Ascorbic Acid Deficiency and support essential biological functions. The substance acts as an essential cofactor for crucial enzymatic processes, most notably Collagen Biosynthesis, which is vital for maintaining the structural integrity of skin, bone, and blood vessels. By ensuring the necessary supply of this nutrient, the compound helps maintain the body’s innate ability to support tissue health and immune preparedness.

Regulatory References

What side effects are possible with Vitacid C?

Possible Side Effects and Safety Information

The safety profile of Vitacid C (Sodium Ascorbate) is characterized by generally dose-dependent adverse reactions, primarily affecting the gastrointestinal system, as documented in official regulatory labeling. Adverse reactions are classified according to frequency in regulatory sources, though incidence often increases with higher intake, particularly doses exceeding 2,000 mg per day.

Officially Documented Adverse Reactions

The most frequently documented adverse effects fall into the Common category and are primarily associated with the Gastrointestinal Disorders system-organ class. These include nausea, vomiting, diarrhea, abdominal discomfort, and general stomach upset. Headache is also a reported reaction under Nervous System Disorders.

Classification	System-Organ Class	Examples Listed in Regulatory Documents
Common	Gastrointestinal Disorders	Nausea, Vomiting, Diarrhea, Abdominal Discomfort
Uncommon	Skin Disorders	Urticaria (Hives)
Rare	Renal and Urinary Disorders	Renal Calculi (Kidney Stones)

Serious Safety Considerations

The label identifies specific, clinically significant risks, generally rare and often tied to high-dose or specific patient populations. A key safety constraint for susceptible individuals is the risk of Hemolysis (breakdown of red blood cells) in patients with Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency.

Additionally, the formation of renal calculi (kidney stones) or oxalate nephropathy is a documented risk, which is specifically linked to the prolonged administration of high doses of ascorbic acid. Caution is also advised for patients with pre-existing conditions that increase the risk of iron overload, such as Hemochromatosis.

Regulatory safety notes also indicate that this substance may interfere with clinical laboratory tests that rely on oxidation-reduction reactions, potentially leading to false results for tests like urinary glucose or serum creatinine.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose of Vitacid C (Ascorbic Acid) is generally associated with low toxicity; however, the regulatory profile highlights specific risks and mandatory emergency actions.

Documented Overdose Presentations

High doses, typically exceeding 2,000 mg (2 g) per day in adults, are officially associated with common gastrointestinal disturbances, including nausea, vomiting, diarrhea, stomach cramps, and headache. More serious documented presentations involve the renal system, such as an increased risk of kidney stone formation and oxalate nephropathy (kidney damage), particularly in individuals with a history of kidney issues.

Population-Specific Overdose Risks

Specific populations face severe risk from high-dose intake. Individuals with Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency are at risk of severe hemolysis (destruction of red blood cells). Patients with conditions like hemochromatosis may experience aggravation due to increased iron absorption.

Emergency Response

Upon suspected overdose, the official guidance is to seek emergency medical attention or call the Poison Help line. If the individual exhibits critical symptoms such as collapse, a seizure, trouble breathing, or inability to be awakened, emergency services must be called immediately.

Therapeutic Uses of Vitacid C

What Vitacid C Treats: Main Uses and Benefits

Vitacid C (Sodium Ascorbate) may be part of symptomatic management of health issues stemming from insufficient Ascorbic Acid status. Its uses are centered around clinical conditions and symptomatic manifestations directly linked to this deficiency. This supplement is commonly used in the management of documented Ascorbic Acid Deficiency, which, in its severe state, is known as Scurvy.

Key Therapeutic Focus

This supplement is commonly used to help with managing symptom clusters associated with compromised connective tissue integrity, systemic weakness, and poor tissue healing. The therapeutic focus includes addressing symptoms such as easy bruising, bleeding gums, and pervasive fatigue related to deficiency. It may assist with maintaining the integrity of blood vessels and soft tissues, contributing to the support of essential physiological functions during periods of deficiency.

It is often applied during periods of convalescence or high metabolic stress, where it contributes to the body's natural recovery processes and may assist with easing the overall symptom load.

Indications and Symptomatic Relief

The primary therapeutic indications for this supplement are the management of Ascorbic Acid Deficiency and the prevention or treatment of Scurvy. It is commonly used to help with addressing the symptomatic burden of deficiency, including bleeding gums, easy bruising, slow wound healing, and general weakness.

Quick Fact: Relief for Structural Symptoms

Vitacid C is considered relevant for addressing symptoms related to the breakdown of blood vessel and connective tissue resilience, such as hemorrhagic manifestations and tissue fragility.

Regulatory References

NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Who can and cannot use Vitacid C (Sodium Ascorbate)

Official regulatory information defines strict eligibility for the use of Vitacid C, focusing on specific patient populations and metabolic conditions. This medicine is primarily intended for Adults and Pediatric Patients age 5 months and older for the treatment of documented Ascorbic Acid Deficiency (Scurvy).

Absolute Contraindications

Vitacid C is contraindicated and must not be used by individuals with a known hypersensitivity to the active ingredient, Sodium Ascorbate. It is also prohibited for patients with certain metabolic disorders, including Oxalate Urolithiasis (kidney stones) or pre-existing Hyperoxaluria, and those with Iron Storage Disorders such as Hemochromatosis

. Use is also contraindicated in patients with severe Renal Insufficiency.

Restrictions and Conditional Use

Use requires caution in patients with Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency due to the risk of hemolysis, often requiring a reduced dose. Patients with a history of kidney stones or renal impairment must use the medicine under strict limitations. For Pregnancy and Lactation, use should not exceed the U.S. Recommended Dietary Allowance (RDA) to avoid potential risks to the infant. Certain high-dose formulations are not recommended for children under 18 years, and caution is advised for Geriatric Patients due to age-related kidney function.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile for Vitacid C (Sodium Ascorbate) is defined by its pharmacokinetic effects on co-administered medicines and its chemical role as a reducing agent, strictly according to regulatory labeling.

Documented Pharmacokinetic and Pharmacodynamic Interactions

Interacting Substance/Class	Official Interaction Pattern
Deferoxamine (Desferrioxamine)	Contraindicated in patients with pre-existing cardiac impairment, as co-administration increases plasma concentrations and carries a risk of cardiotoxicity.
Oral Ethinyl Estradiol	Increases the elimination half-life and overall exposure of this oral contraceptive component.
Fluphenazine	Co-administration increases the plasma concentration of this medicine.
Propranolol	Co-administration reduces the plasma concentration of this medicine.
Oral Iron Salts	Causes a pharmacodynamic effect that increases the gastrointestinal absorption of iron.

Mechanism of Action

Core Mechanism: Supporting Structural Protein Synthesis

This domain addresses the drug's role as an essential cofactor for hydroxylase enzymes involved in the collagen biosynthesis pathway. By ensuring the stability of the collagen structure, this mechanism influences the structural coherence of connective tissues throughout the body, including skin, cartilage, and the walls of blood vessels.

Modulating Oxidation and Cellular Defense

This mechanism operates by acting as an electron donor and reducing agent throughout the body, allowing it to directly neutralize reactive oxygen species (ROS) or free radicals. This core action limits the oxidative effects on cellular components, thereby influencing the cellular redox state and supporting redox-sensitive processes within immune cells.

Enhancing Iron Bioavailability

This domain focuses on the chemical transformation of dietary iron in the digestive tract. By chemically reducing ferric iron (Fe^3+) to the more easily absorbed ferrous form (Fe^2+), the drug influences the biological utilization of this essential mineral. This process is integral to supporting processes like the efficient formation of heme and the body's oxygen-carrying capacity.

Dosage and Administration Information

How Vitacid C is Used: Administration Guidelines

The usage of Vitacid C (Sodium Ascorbate/Ascorbic Acid) is defined by the intended route of administration and the required dosage to manage Ascorbic Acid deficiency. The medicine is available for both oral and parenteral use.

Administration Routes and Dosing

Usage Type	Approved Route	Adult Daily Dose (Typical)	Frequency
Oral Treatment	Oral (Tablet, Liquid)	100 mg to 250 mg	Once or twice daily
IV Treatment	Intravenous (IV) Injection	200 mg	Once daily (up to 7 days)
Prophylaxis	Oral	50 mg to 200 mg	Once daily

For oral consumption, the medicine may be taken with or without food, and liquid forms may be mixed with cereal or fruit juice. If a dose is missed, it should be skipped if it is almost time for the next scheduled dose, and dosing should return to the regular schedule.

Parenteral Preparation and Special Rules

Intravenous (IV) administration follows strict procedural requirements: the injectable solution must be diluted in a suitable infusion fluid (such as Dextrose or Saline) prior to administration, and the final solution must be isotonic. The injection must be given as a slow intravenous infusion and the maximum recommended duration for the IV regimen is seven days.

Population-Specific Rules

Specific adjustments are provided for certain groups. For example, IV dosing for pediatric patients is lower, typically 50 mg to 100 mg once daily, depending on age. Additionally, patients with Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency are instructed not to exceed the established recommended daily allowance for their age group.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Vitacid C (Sodium Ascorbate)

Evidence for Management of Ascorbic Acid Deficiency

The primary research base for Vitacid C centers on its established function in correcting Ascorbic Acid Deficiency, a condition in which the body lacks enough Vitamin C. The evidence in this area is based on a foundational body of research, including historical clinical data and regulatory recognition.

Research was studied for its ability to resolve the symptoms of deficiency. This included historical human depletion studies, along with numerous case reports and chart reviews. These studies research examined how quickly deficiency-related symptoms—such as bleeding gums, fatigue, and wound healing status—evolved when the compound was observed in individuals receiving administration. The studies also monitored if biomarker shifts, such as changes in blood Ascorbic Acid concentrations, were observed.

The findings describe patterns observed where symptoms evolved in individuals receiving the compound. Changes in clinical status were observed alongside corresponding shifts in Ascorbic Acid levels in the blood. This historical consistency contributes to the broader evidence landscape that regulators rely on in relation to the compound's use.

Research on Supportive and Adjunctive Uses

Beyond correcting a confirmed deficiency, research has explored Vitacid C for various supportive and adjunctive uses. This area relies mainly on systematic reviews and meta-analyses of Randomized Controlled Trials (RCTs) that have explored its use in non-deficient contexts.

These trials was evaluated in settings focusing on outcomes related to systemic or functional imbalance, such as changes in intermediate biomarkers like blood pressure and lipid profiles. Research examined the compound in contexts involving co-administration with oral iron supplements, with studies monitoring outcomes related to iron absorption.

Findings were observed in some studies to include patterns related to intermediate endpoints like blood pressure. Other research contributes to understanding that results often differ depending on the specific patient group or the type of outcomes measured. The evidence often is limited to demonstrating consistency across all measured endpoints.

Current Evidence Gaps and Areas of Uncertainty

While the role of Vitacid C in treating deficiency is historically well-established, there are areas where research is still ongoing or evidence is limited.

Long-term effects are not fully established by existing high-quality RCTs, particularly regarding the durability of response or the sustained impact of supplementation on chronic disease prevention over many years. The findings for adjunctive uses are characterized by variability and inconsistency across studies, and certainty remains low regarding the use of supplementation in various health contexts.

Key Studies & References

Ascorbic Acid: Drug Information (MedlinePlus)

Frequently Asked Questions (FAQ)

Common questions about Vitacid C (FAQ)

Q: How should Vitacid C be administered intravenously (IV)?

A: According to official administration guidelines, Vitacid C for intravenous use must be diluted in an appropriate fluid. The diluted solution is typically administered by a healthcare professional as a slow intravenous infusion. This is the official procedure for administration.

Q: What storage temperature is required for Vitacid C?

A: Official product information states that Vitacid C should be stored at temperatures not exceeding 30 C to maintain its stability. It is also important that the medicine is protected from heat, moisture, and direct sunlight.

Q: How does Sodium Ascorbate compare to pure Ascorbic Acid?

A: Vitacid C contains Sodium Ascorbate, which is a form of Vitamin C that has been buffered and is less acidic than pure Ascorbic Acid. Official information notes that Sodium Ascorbate, being buffered, may offer improved digestive tolerability compared to non-buffered Ascorbic Acid.

Q: What is the color or appearance of the Vitacid C tablet or liquid?

A: Based on the official product descriptions, the powder or content found within the capsule or tablet is typically described as a white to very faintly yellow crystalline powder.

Q: What is the difference between prophylaxis and treatment dosing?

A: Regulatory documents distinguish between prophylaxis and treatment for Ascorbic Acid deficiency. Prophylaxis refers to using the medicine at lower doses to prevent a deficiency from occurring. Treatment involves using dose regimens intended to correct a confirmed deficiency, as determined by a healthcare provider.

Q: How long does it take for Vitacid C to start working to improve symptoms of deficiency?

A: Official product information and studies on deficiency suggest that clinical improvement may be observed within the first 1 to 2 weeks of starting treatment. These improvements often relate to the healing of bleeding gums, reduction in fatigue, and other deficiency-related symptoms.

How should Vitacid C be stored and disposed of?

How to Store and Dispose of Vitacid C (Sodium Ascorbate)

Official regulatory documents define strict conditions to maintain the stability of Sodium Ascorbate.

Storage Conditions

Vitacid C must be protected from light and moisture and kept in its original container, tightly closed.

Temperature requirements vary by formulation, generally requiring storage below 25 C or 30 C. Injectable forms must be stored at controlled room temperature and must not be frozen.

For certain oral containers, the in-use shelf-life is 100 days after first opening.

Disposal

Expired or unused medicine must be kept out of the sight and reach of children.

Disposal must be conducted in accordance with local requirements. The product must not be discarded in wastewater or household waste, and drug take-back locations are recommended.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.